Table 3.
Five-Year cumulative incidence of adverse events according to CRSS.
| CRSS, 0 (a) | CRSS > 0–6 (b) | CRSS > 6–12 (c) | CRSS > 12 (d) | P-Value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trend | a vs. b* | a vs. c* | a vs. d* | b vs. c* | b vs. d* | c vs. d* | |||||
| All-cause death | 5.6% (33) | 2.4% (16) | 7.6% (42) | 8.9% (58) | 0.001 | 0.195 | 0.235 | 0.01 | 0.015 | <0.001 | 0.168 |
| Cardiac death | 3.3% (20) | 1.6% (10) | 3.2% (18) | 6.5% (43) | <0.001 | 0.282 | 0.929 | 0.006 | 0.259 | <0.001 | 0.01 |
| Myocardial infarction | 3.0% (18) | 3.9% (26) | 4.2% (23) | 10.6% (70) | <0.001 | 0.058 | 0.049 | <0.001 | 0.899 | 0.017 | 0.036 |
| Unplanned revascularization | 6.5% (39) | 11.9% (79) | 12.5% (69) | 16.8 (110) | <0.001 | 0.005 | 0.001 | <0.001 | 0.448 | 0.007 | 0.081 |
| Stroke | 6.6% (39) | 4.8% (32) | 7.2% (40) | 12.1% (80) | <0.001 | 0.647 | 0.301 | <0.001 | 0.139 | <0.001 | 0.01 |
| MACCE | 17.6% (105) | 17.9% (119) | 25.1% (138) | 33.6% (220) | <0.001 | 0.216 | <0.001 | <0.001 | 0.019 | <0.001 | 0.002 |
Event rates are Kaplan-Meier estimates, % (n).
*
Adjusted significance level is 0.008. CRSS, clinical residual SYNTAX score, MACCE, major adverse cardiovascular and cerebrovascular events.